To explore the antitumor mechanism of the vaccine, a prophylactic and therapeutic model of melanoma containing the human MUC1 gene was used to evaluate the antitumor effect of the vaccine in C57BL/6 mice. The gene discussed is MUC1; the disease is melanoma.